Role of 5-HT2A and 5-HT2C receptor subtypes in the two types of fear generated by the elevated T-maze (Q34450355)

2 August 2017

Role of 5-HT2A and 5-HT2C receptor subtypes in the two types of fear generated by the elevated T-maze (English)

1 reference

2 August 2017

Mora PO

1

1 reference

2 August 2017

Netto CF

series ordinal

2

1 reference

2 August 2017

Graeff FG

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

Pharmacology, Biochemistry and Behavior

2 August 2017

1 reference

2 August 2017

58

1 reference

2 August 2017

1051-1057

1 reference

2 August 2017

4

1 reference

Mediation by serotonin of the antiaversive effect of zimelidine and propranolol injected into the dorsal midbrain central grey

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

5-HT and mechanisms of defence

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea hydrochloride: the first selective 5-HT1C receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Role of 5-HT in stress, anxiety, and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Role of the amygdala and periaqueductal gray in anxiety and panic

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Functional correlates of serotonin 5-HT1 recognition sites

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Effects of serotonin receptor antagonists on PAG stimulation induced aversion: different contributions of 5HT1, 5HT2 and 5HT3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Serotonin and anxiety revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

5-HT receptors: past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Anti-aversive role of serotonin in the dorsal periaqueductal grey matter.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Are 5-HT2 antagonists endowed with anxiolytic properties in rodents?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

The elevated T-maze: a new animal model of anxiety and memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900057-9

7 January 2021

10.1016/S0091-3057(97)00057-9

Identifiers

DOI

1 reference

2 August 2017

1 reference